Patient adherence to cognitive-behavioral therapy predicts long-term outcome in obsessive-compulsive disorder

Journal of Clinical Psychiatry

Volumn 73, Issue 9, 2012, Pages 1265-1266

  Simpson, Helen Blair ^a,b   Marcus, Sue M ^a,b   Zuckoff, Allan ^c   Franklin, Martin ^d   Foa, Edna B ^d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Division of Biostatistics New York State Psychiatric Institute ^*  (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; CLINICAL ARTICLE; COGNITIVE THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPOSURE AND RITUAL PREVENTION; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EX RP ADHERENCE SCALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84866483658     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12l07879     Document Type: Letter

References (8)

1. Simpson HB, Maher MJ, Wang Y, et al. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder. J Consult Clin Psychol. 2011;79(2):247-252. doi:10.1037/a02659 PubMed
2. Simpson HB, Zuckoff AM, Maher MJ, et al. Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder. Behav Res Ther. 2010;48(10):941-948. doi:10.1016/j.brat.2010.05.026 PubMed
3. Kozak MJ, Foa EB. Mastery of Obsessive-Compulsive Disorder: A Cognitive-Behavioral Approach. San Antonio, TX: The Psychological Corporation; 1997.
4. Simpson HB, Maher M, Page JR, et al. Development of a patient adherence scale for exposure and response prevention therapy. Behav Ther. 2010;41(1):30-37. doi:10.1016/j.beth.208.12.02 PubMed
5. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. doi:10.101/archpsyc.1989.01810104807 PubMed
6. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 2: validity. Arch Gen Psychiatry. 1989;46(11):1012-1016. doi:10.101/archpsyc.1989.01810105408 PubMed
7. Whittal ML, Robichaud M, Thordarson DS, et al. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: a 2-year follow-up of two randomized trials. J Consult Clin Psychol. 2008;76(6):1003-1014. doi:10.1037/a013076 PubMed
8. Tolin DF, Diefenbach GJ, Gilliam CM. Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy and costs. Depress Anxiety. 2011;28(4):314-323. doi:10.102/da.20804 PubMed